Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

TriAb prolongs disease progression in breast cancer patients

Sep. 27, 1999

GM-CSF and MDX-H210 assessed in pilot trial in cancer patients

Sep. 24, 1999

FDA accepts IND for ImmunoGen's tumor-activated prodrug

Sep. 23, 1999

Kyowa Hakko begins clinical testing of MAb as melanoma Rx

Sep. 21, 1999

Genzyme Molecular Oncology reports preclinical results, collaboration for aaATIII

Sep. 21, 1999

Biomira updates development activites at recent healthcare conference

Sep. 17, 1999

Boehringer Ingelheim's TNF-alpha-1a launched in Europe for soft tissue sarcoma

Sep. 16, 1999

M-Vax nearing commercialization in several markets

Sep. 16, 1999

Genzyme Molecular Oncology announces initiation of breast cancer vaccine trial

Sep. 16, 1999

Transgene commences phase I trial for treatment of cervical cancer

Sep. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...